Tender Details
Ref No 8294730
Document

Tender Notice

Bidding

Not specified

Short Description

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Para. 8 Sgb V For The Active Ingredient Omalizumab

Deadline *
Date 10 Aug 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Germany
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

Qualification Scheme Construction Projects

Qualification Scheme Technical Advice

Sdp Supply Of Medicinal Products

Qualification System For Data Center Infrastructure Renewal

WhatsApp Chat